Higher PFAS levels reduce blood sugar improvements after teen bariatric surgery
A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before…
Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and…
New antibody strategy shows promise for halting cyst growth in polycystic kidney disease
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the…
Dash diet cuts diabetes complications by targeting blood pressure kidney health and inflammation
A nutrient-rich eating pattern originally built for blood pressure control is emerging as a powerful ally against diabetes…
Earlier blood transfusion reduces heart complications post-surgery in high-risk patients
An earlier blood transfusion- done when hemoglobin levels were higher – after major general or vascular surgery among…
Using estimated risks and preferences to justify intensive BP control in CKD patients
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney…
SGLT2 inhibitors show consistent cardio-renal protection in 70,000 patients
In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two companion…
Pediatric patients with primary glomerular diseases may experience faster kidney function decline
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets…
Mismatch in kidney tests may reveal hidden health risks
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart…
Pioneering technology enables scalable production of human kidney organoids
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research…
WHO reviews highlight limited long-term data on GLP-1 drug safety
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies…
Scripps Research professor wins $3.2 million grant to unravel the mysteries of type 1 diabetes
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2…